🇺🇸 FDA
Patent

US 10272034

Auris formulations for treating otic diseases and conditions

granted A61KA61K2039/505A61K31/05

Quick answer

US patent 10272034 (Auris formulations for treating otic diseases and conditions) held by The Regents of the University of California expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/505, A61K31/05, A61K31/13, A61K31/137